Skip to main content

News

FX offers hope for Reuters

LONDON -- Dealing 3000, Reuters’ FX trading system, lost some ground last year, but FX provided some joy for the information and technology giant in its annual results published last week.

ABN Amro overhauls FM division

AMSTERDAM -- ABN Amro last week completed a thorough overhaul of its financial markets division, in a reorgnisation that will affect foreign exchange in two key ways.

RBA unwinds Australian dollar holding

SYDNEY -- The Reserve Bank of Australia took profits on its Australian dollar holdings earlier this year, selling nearly A$500 million, according to the bank’s February bulletin.

BIS expands derivatives data

BASEL -- The Bank for International Settlements said last week that it is expanding its statistics on banks’ country risk exposures to include data on derivatives exposures to individual countries.

Rusnak lessons still unheeded

NEW YORK -- Global banks are yet to implement key recommendations to limit rogue trading losses, one year on from John Rusnak’s record $700 million forex fraud.

BoA loses global market head

NEW YORK -- Duncan Goldie-Morrison, Bank of America’s global markets chief will leave the firm at the end of this month following a reorganisation of BoA’s global markets group.

GFI closes FX options mark-to-market gap

NEW YORK -- Solving the problem of marking FX options to market came a step closer to being resolved last week, with the launch of a new ‘revaluation fixing’ service from New York-based interdealer broker GFI.

Forex unhurt as ING cuts in New York

NEW YORK -- Foreign exchange has been spared in a cull of staff at ING in New York. Only one forex position was cut, said a bank spokesperson, in a spate of departures in January and February.

Blix report boosts dollar

NEW YORK -- The US dollar rallied slightly in the wake of United Nations chief weapons inspector Hans Blix’s report on Iraq late last Friday.

You need to sign in to use this feature. If you don’t have a FX Markets account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: